| Dose Optimisation of Stavudine for the Treatment of HIV Infection (NCT02670772) | Willem Daniel Francois Venter | 2012-07-01 |
| Tripterygium Wilfordii Hook F (TwHF) Treatment for Immune Non-responders With HIV-1 Infection (NCT01666990) | Beijing 302 Hospital | 2012-06-01 |
| HIV, Buprenorphine, and the Criminal Justice System (NCT01550341) | Yale University | 2012-02-23 |
| Nevirapine Dosing in Neonates for Prophylaxis of Mother-to-Child-Transmission (MTCT) of HIV Infection (NCT02166502) | The Hospital for Sick Children | 2012-02-01 |
| Evaluation of Raltegravir Plus Maraviroc Therapy in Controlled HIV Patients Presenting With Lipohypertrophy (NCT01420523) | ANRS, Emerging Infectious Diseases | 2011-12-01 |
| Platelets Study: Influence of the Antiretroviral Treatment on the Platelet Physiology During HIV Infection (NCT02532348) | Centre Hospitalier Universitaire de Saint Etienne | 2011-08-01 |
| Maternal-fetal CD4 Microchimerism in HiV Exposed Newborns After Spontaneous Delivery and Cesarean Section (NCT01450059) | Johann Wolfgang Goethe University Hospital | 2011-08-01 |
| Development of Method of Fructose Identification in Urine to Detect the Viral Infection (NCT01638312) | Kaohsiung Medical University Chung-Ho Memorial Hospital | 2011-06-01 |
| A Safety Study Of A Single Vaginal Administration Of P2G12 Antibody In Healthy Female Subjects (NCT01403792) | University of Surrey | 2011-06-01 |
| Single Ascending Dose (SAD)/Multiple Ascending Dose(MAD) Safety/Pharmacokinetic (PK) Study of KM-023 (NCT01348516) | Kainos Medicine Inc. | 2011-05-01 |
| HIV and Drug Use in Georgian Women (NCT01331460) | University of North Carolina, Chapel Hill | 2011-04-01 |
| Post-Exposure Prophylaxis in Health Care Workers (NCT01234116) | Henry Ford Health System | 2011-02-01 |
| Pharmacokinetic Study of Raltegravir in Human Immunodeficiency Virus/Hepatitis C Virus (HIV/VHC) Coinfected Patients With Advanced (Child-Pugh C) Hepatic Cirrhosis (NCT01289951) | Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal | 2010-12-01 |
| Alcohol Pharmacotherapy for HIV+ Prisoners (NCT01077310) | Yale University | 2010-08-01 |
| Computer-Assisted Tailored Cue-card Health [CATCH] Study (NCT01170741) | RTI International | 2010-06-01 |
| Tenofovir, Emtricitabine, Efavirenz and Atazanavir Pharmacokinetics in the Aging HIV-Infected Population (NCT01180075) | University of North Carolina, Chapel Hill | 2010-05-01 |
| Notification of Donors With Positive Microbiology Markers (NCT01050881) | NHS Blood and Transplant | 2010-03-01 |
| Europe-Africa Research Network for Evaluation of Second-line Therapy (NCT00988039) | Justine Boles | 2010-03-01 |
| Pharmacokinetic Interactions Between an Herbal Medicine (African Potato) and Antiretroviral Agents (Lopinavir/Ritonavir) (NCT01227590) | University of California, San Francisco | 2010-02-01 |
| Intervention of HIV, Drug Use and the Criminal Justice System in Malaysia (NCT02396979) | Yale University | 2010-01-01 |
| Comparison of Concentration-time Course of Plasma and Intracellular Raltegravir in Healthy Volunteers (NCT01027182) | Changi General Hospital | 2009-12-01 |
| A Phase I Study of Quadrivalent Human Papilloma Virus (HPV) (Types 6, 11, 16, 18) Recombinant Vaccine in HIV-Infected and HIV-Negative Pre-Adolescents, Adolescents, and Young Adults (NCT00798265) | National Cancer Institute (NCI) | 2009-06-29 |
| Pilot Study of a Raltegravir Based NRTI Sparing Regimen (NCT00814879) | Yale University | 2009-05-01 |
| An Open Label Pharmacokinetic, Safety And Efficacy Study Of Maraviroc In Combination With Background Therapy For The Treatment Of HIV-1 Infected, CCR5 -Tropic Children (NCT00791700) | ViiV Healthcare | 2009-04-22 |
| Maraviroc Versus Etravirine In Combination With Antiretroviral Therapy In Drug Experienced HIV And Hepatitis Co-Infected Patients (NCT00782301) | ViiV Healthcare | 2009-03-01 |
| Raltegravir (Isentress/MK-0518) and HIV-1 Infected CD4 Cells During Acute/Early HIV-1 (NCT00781287) | University of Washington | 2009-02-01 |
| Fetal HIV Transmission Risk and Duration of Membrane Rupture (NCT01616823) | Unity Health Toronto | 2009-01-01 |
| Omega-3 Supplementation in HIV Patients With Therapeutic Lifestyle Change Diet. (NCT02537236) | Instituto Mexicano del Seguro Social | 2009-01-01 |
| A Study of Raltegravir in a Diverse Cohort of HIV-Infected Patients (0518-055) (NCT00764946) | Merck Sharp & Dohme LLC | 2008-10-01 |
| Problems With Immune Recovery in the Gut Tissue (NCT01460433) | University of Minnesota | 2008-09-01 |
| Tissue Drug Levels of HIV Medications (NCT01490346) | University of Minnesota | 2008-09-01 |
| Kaletra in Combination With Antiretroviral Agents (NCT01076179) | AbbVie (prior sponsor, Abbott) | 2008-09-01 |
| Mentor Mothers: A Sustainable Family Intervention in South African Townships (NCT00972699) | University of California, Los Angeles | 2008-07-01 |
| Eltrombopag To Reduce The Need For Platelet Transfusion In Subjects With Chronic Liver Disease And Thrombocytopenia Undergoing Elective Invasive Procedures (NCT00678587) | GlaxoSmithKline | 2008-06-01 |
| Prospective Observational Epidemiologic Study of Maraviroc's Safety (NCT00665561) | ViiV Healthcare | 2008-03-31 |
| Treatment of Acute Hepatitis C Virus in HIV Co-Infection (NCT00845676) | University of California, San Francisco | 2008-03-01 |
| Adjusting Antiretroviral Therapy Dosage Using Therapeutic Drug Monitoring (NCT00836212) | University Hospital, Geneva | 2008-03-01 |
| Safety And Efficacy Study Of CP-675,206 In HIV-Infected Patients (NCT00488995) | Pfizer | 2007-07-01 |
| Treatment Simplification by Darunavir/Ritonavir 800/100 mg Once a Day Versus a Triple Combination Therapy With Darunavir/Ritonavir (NCT00458302) | Janssen-Cilag International NV | 2007-06-01 |
| Efficacy Study of Different Laboratory Management Strategies and Drug Regimens in HIV-infected Children in Africa (NCT02028676) | Medical Research Council | 2007-03-01 |
| Hepatic Safety of Currently Used Antiretroviral Regimens in Patients With Chronic Hepatitis Under Real Life Conditions (NCT01908660) | Valme University Hospital | 2007-01-01 |
| Study on the Usage, Dosing, Tolerability, and Effectiveness of Kaletra Tablet (NCT01097655) | AbbVie (prior sponsor, Abbott) | 2006-08-01 |
| Randomized, Double-Blind Study Comparing Dexelvucitabine (DFC) to Lamivudine (3TC) in Subjects With Resistance to NRTIs, PIs, and NNRTIs (NCT00300573) | Incyte Corporation | 2006-04-01 |
| SP01A: The Study of an Oral Entry Inhibitor in Treatment-Experienced HIV Patients (NCT00299897) | Samaritan Pharmaceuticals, Inc | 2006-03-01 |
| Omacor and Cardiovascular Risk Factors in HIV Patients on HAART Treatment (NCT00296153) | Pronova BioPharma | 2006-02-01 |
| Ritonavir-Boosted GS-9137 vs. Ritonavir-Boosted Protease Inhibitor(s) in Combination With Background ART. (NCT00298350) | Gilead Sciences | 2006-02-01 |
| Study of Interferon-Gamma in the Complex Treatment of Patients Infected With HIV and Tuberculosis (NCT05065905) | SPP Pharmaclon Ltd. | 2006-01-19 |
| Predictors of Antiretroviral Pharmacokinetics in HIV-infected Women With Virologic Suppression (NCT01613157) | Canadian Immunodeficiency Research Collaborative | 2006-01-01 |
| Buprenorphine and Integrated HIV Care (NCT00317460) | Yale University | 2005-09-01 |
| Study to Assess Safety and Quality of Life of Patients Using Biojector Versus Needles for Fuzeon Administration (NCT00333736) | Canadian Immunodeficiency Research Collaborative | 2005-05-01 |
| Evaluate Tolerability of a Recombinant DNA HIV-1 Vaccine in Healthy Adults (NCT00187148) | St. Jude Children's Research Hospital | 2005-02-01 |
| Redistribution of Fat and Metabolic Change in HIV Infection: Protocol 2 (FRAM Fat 2) (NCT00244803) | Johns Hopkins University | 2005-01-01 |
| Safety, Efficacy and Psychological Effects of Treating Antiretroviral Drug-Induced Facial Lipoatrophy With Bio-Alcamid (NCT00333684) | Canadian Immunodeficiency Research Collaborative | 2004-12-01 |
| HIV Prevention in the Primary Care Setting (NCT00381524) | University of Alabama at Birmingham | 2004-06-01 |
| Kaletra: Therapy With Double Protease Inhibitors (NCT01075191) | AbbVie (prior sponsor, Abbott) | 2004-01-01 |
| Smoking Cessation for HIV/AIDS Patients (NCT00502827) | M.D. Anderson Cancer Center | 2004-01-01 |
| Safety and Efficacy of Kaletra in ARV Therapy Experienced Patients (NCT00648999) | AbbVie (prior sponsor, Abbott) | 2003-11-01 |
| Leukapheresis to Obtain Lymphocytes for Studies on Antiretroviral Naive HIV-infected Patients (NCT00333892) | Canadian Immunodeficiency Research Collaborative | 2003-08-01 |
| Relaxation Response With Acupuncture for HIV Patients (NCT00064740) | National Center for Complementary and Integrative Health (NCCIH) | 2003-07-01 |
| Capravirine (AG1549) in Combination With Viracept and Two NRTIs in HIV Infected Patients Who Failed an Initial NNRTI Containing Regimen (NCT00051844) | Pfizer | 2002-08-01 |
| Evaluation of Kaletra Therapy Over the Long-term (NCT01083810) | Abbott | 2001-06-01 |
| Preventive Therapy for Tuberculosis in HIV Infected Persons (NCT00351702) | Tuberculosis Research Centre, India | 2001-02-01 |
| Drug Use Investigation of Kaletra (NCT01076972) | Abbott | 2000-12-01 |
| Special Investigation of Kaletra in Pregnant Women (NCT01076985) | Abbott | 2000-12-01 |
| Evaluation of the Safety of a Polyvalent Virus in Healthy Adults (NCT00187044) | St. Jude Children's Research Hospital | 1997-10-01 |
| Nice Human Immunodeficiency Virus (HIV) Cohort (NCT03690063) | Centre Hospitalier Universitaire de Nice | 1996-01-01 |
| Interactions of Hepatitis C Viral (HCV) Dynamics and Immune Activation in HIV Coinfected Patients During HCV Treatment (NCT00909129) | Karolinska Institutet | |